![Laura Fletcher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laura Fletcher
Direktor/Vorstandsmitglied bei
Stratosvir Ltd.
Profil
Laura Fletcher was the founder of ProXara Biotechnology Ltd., founded in 2001, and held the title of Senior Scientific Officer in 2010.
Dr. Fletcher is currently Director at Neobe Therapeutics Ltd. since 2021 and Director at Stratosvir Ltd. since 2021.
Former jobs include Director at Cellinta Ltd. in 2020 and Head of Business Development & Venture Portfolio at Deep Science Ventures Ltd. Education includes an undergraduate degree earned in 1996 and a doctorate earned in 2000 from the University of Bristol.
Aktive Positionen von Laura Fletcher
| Unternehmen | Position | Beginn |
|---|---|---|
Stratosvir Ltd.
 Stratosvir Ltd. Miscellaneous Commercial ServicesCommercial Services Develops viral immunotherapies to target cancer | Direktor/Vorstandsmitglied | 01.04.2021 |
Neobe Therapeutics Ltd.
 Neobe Therapeutics Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology field | Direktor/Vorstandsmitglied | 14.04.2021 |
Ehemalige bekannte Positionen von Laura Fletcher
| Unternehmen | Position | Ende |
|---|---|---|
Cellinta Ltd.
 Cellinta Ltd. Investment ManagersFinance Functions as an alternative investment manager for healthcare industry | Direktor/Vorstandsmitglied | 31.12.2020 |
Deep Science Ventures Ltd.
 Deep Science Ventures Ltd. Investment ManagersFinance Deep Science Ventures invests in private companies located in the United States and Europe. The firm focuses on sectors such as agriculture, computation, climate, and pharmaceuticals and education. It participates in pre-seed, seed, and early stage capital financing requirements. | Private Equity Investor | - |
ProXara Biotechnology Ltd.
 ProXara Biotechnology Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer | Gründer | - |
Ausbildung von Laura Fletcher
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
94
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProXara Biotechnology Ltd.
ProXara Biotechnology Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer | Health Technology |
Deep Science Ventures Ltd.
Deep Science Ventures Ltd. Investment ManagersFinance Deep Science Ventures invests in private companies located in the United States and Europe. The firm focuses on sectors such as agriculture, computation, climate, and pharmaceuticals and education. It participates in pre-seed, seed, and early stage capital financing requirements. | Finance |
Cellinta Ltd.
Cellinta Ltd. Investment ManagersFinance Functions as an alternative investment manager for healthcare industry | Finance |
Stratosvir Ltd.
Stratosvir Ltd. Miscellaneous Commercial ServicesCommercial Services Develops viral immunotherapies to target cancer | Commercial Services |
Neobe Therapeutics Ltd.
Neobe Therapeutics Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology field | Health Technology |
